In a world increasingly shaped by scientific advancement and evolving societal norms, the realm of human reproduction has ...

The dental implantology software market is projected to expand from USD 240.6 million in 2025 to USD 402 million by 2035, ...

Independent report confirms Ambience Healthcare's AI platform reduces clinician burnout, enhances patient care, and strengthens financial and compliance outcomes SAN FRANCISCO, CA / ACCESS Newswire / ...

SEATTLE, WASHINGTON / ACCESS Newswire / June 20, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on ...

Pending the European Commission final decision, regimen offers a new standard of care for eligible MCL patients[1],[2] Positive opinion reinforces Phase 3 TRIANGLE study results by the European MCL ...

If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...

Exhibiting Next Week at HFMA Annual Conference in Denver DENVER, COLORADO / ACCESS Newswire / June 20, 2025 / IKS Health has been named the top-rated provider of outsourced Revenue Cycle Management ...

The global MRI market will rise from USD 6.47 billion in 2025 to USD 9.76 billion by 2035, growing at a CAGR of 4.2%. By product type, closed MRI systems will dominate with a 68.5% share in 2025, ...

The global animal artificial insemination market is valued at USD 2.4 billion in 2025 and is slated to be worth USD 4.2 billion by 2035, expanding at a CAGR of 5.4%. This growth is primarily driven by ...

The global real world evidence (RWE) solutions market is projected to grow from USD 52.4 billion in 2025 to USD 136.2 billion by 2035, advancing at a solid compound annual growth rate (CAGR) of 10.2% ...

The global digital stethoscope market is worth USD 327.64 million in 2025 and is poised to reach USD 570.36 million by 2035, which shows a CAGR of 5.7% over the forecast period. The rising demand for ...

Mipletamig-driven clinical validation of the CRIS-7 derived CD3-binding domain underpins Aptevo's expansion from hematologic to solid tumorsNew candidate APVO455 targets Nectin-4+ cancers, joins ...